TD Waterhouse Canada Inc. Sells 4,097 Shares of Astera Labs, Inc. $ALAB

TD Waterhouse Canada Inc. lessened its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 24.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,337 shares of the company’s stock after selling 4,097 shares during the period. TD Waterhouse Canada Inc.’s holdings in Astera Labs were worth $2,052,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Perigon Wealth Management LLC increased its stake in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC increased its stake in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC increased its stake in Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares during the period. Venturi Wealth Management LLC increased its stake in Astera Labs by 2.6% during the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after acquiring an additional 84 shares during the period. Finally, Great Valley Advisor Group Inc. increased its stake in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after acquiring an additional 90 shares during the period. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent research reports. UBS Group initiated coverage on Astera Labs in a research note on Tuesday. They set a “neutral” rating and a $180.00 price objective on the stock. Royal Bank Of Canada reiterated an “outperform” rating and issued a $250.00 price target on shares of Astera Labs in a research note on Tuesday. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Citigroup assumed coverage on Astera Labs in a research note on Thursday, April 2nd. They issued a “buy” rating and a $200.00 price target on the stock. Finally, Loop Capital assumed coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $199.74.

Insider Transactions at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,757 shares of the business’s stock in a transaction on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the sale, the director owned 67,144 shares in the company, valued at $11,758,257.28. The trade was a 5.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Up 1.8%

Shares of ALAB stock opened at $197.54 on Friday. The firm has a market capitalization of $33.83 billion, a P/E ratio of 161.92, a P/E/G ratio of 3.82 and a beta of 1.78. Astera Labs, Inc. has a twelve month low of $61.18 and a twelve month high of $262.90. The stock’s fifty day simple moving average is $132.20 and its 200 day simple moving average is $154.08.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Analyst price‑target upgrades and “buy” calls (RBC, Loop Capital and others) have pushed optimism around ALAB’s multi‑year revenue runway; recent coverage and PT upgrades helped drive buying interest. Read More.
• Positive Sentiment: Large cloud/AI deal flow (notably the Anthropic/Amazon cluster) is being read as incremental demand for Astera’s CXL/PCIe retimers and fabric products — a direct revenue lever if hyperscalers convert commitments into orders. Read More.
• Positive Sentiment: Recent results show rapid top‑line growth and an EPS beat (record revenue and raised Q1 guidance), supporting the case that Astera’s products are gaining adoption in AI racks. Read More.
• Positive Sentiment: Institutional demand: large fund buys (e.g., BlackRock and others increasing positions) and renewed hedge‑fund interest are amplifying momentum. Read More.
• Neutral Sentiment: UBS started coverage with a Neutral rating and a $180 target — the research acknowledges strong AI networking fundamentals but places a conservative near‑term view on valuation vs. upside expectations. Read More.
• Neutral Sentiment: Upcoming Q1 earnings (early May) are an obvious near‑term catalyst: results and customer commentary can either validate the momentum or inject volatility depending on order visibility and guidance. Read More.
• Negative Sentiment: Heavy insider selling (CEO and other insiders have sold sizable blocks in recent weeks; trades were done under 10b5‑1 plans) creates a headline risk and can sap momentum even if pre‑arranged. Read More.
• Negative Sentiment: High valuation and volatility: ALAB trades at a rich multiple (high P/E) and is subject to momentum swings — downside can amplify quickly if analyst sentiment or hyperscaler order visibility cools. Read More.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.